Beta
169353

OCULAR BOAVAILABILIIY OF TRIAMICINOLONE ACETONIDE COMPLEX FROM DIFFERENT OPHIHALMIC PREPARATIONS IN RABBITS’ EYES

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

-

Abstract

The effect of beta-cyclodextrin (β-CyD) on the solubility , release characteristics and ocular bioavailability of triamcinolone acetonide (TA) from ophthalmic gels and ocuserts were investigated. Triamcinolone acetonide- β-CyD complex was prepared by kneading method in a molar ratio of 1:1. The ophthalmic gels [carbopol 934. hydroxy propy] methyl cellulose (HPMC). sodium alginate| and ocuserts (HPMC and carbopol 934 combination. sodium alginate and carbopol 934 combination) were prepared using 0.1% of the drug or its equivalent amount of complex with β-CyD. The in vivo study was performed on male albino rabbits. The drug concentrations were determined in different eye tissues and aqueous humor of the rabbits after 1. 2.4. and 6 hr of the application by HPLC method.
The obtained results revealed that. the solubility of TA was increased  linearly as a function of β-CyD  concentration following AL type phase solubility diagram. The percent released of the drug from the prepared formulations containing free TA could be arranged in the following order: HPMC and carbopol 934 combination ocuserts > sod. alginate and the percent released of the drug from ophthalmic gels and ocuserts containing the drug complex with β-CyD was significantly higher than that of the free drug. Concerning the ocular bioavailability, all tested formulations provided the highest Cmax Of the drug in conjunctiva folloWed by cornea, i is-ciliary bod!. then the aqueous humor. except that after 6 hr. it was high in cornea followed by iris-ciliary body. conjunctiva and then the aqueous humor. The peak time of maximum drug concentration (Tmax) in rabbits eye tissues and aqueous humor was 4 hr for all ophthalmic gels and ocuserts. The total ocular bioavailability of triamcinolone acetonide was improved when the drug was complexed with β-CyD.

DOI

10.21608/zjps.2009.169353

Authors

First Name

Abd El-Gawad

Last Name

Abd El-Gawad

MiddleName

-

Affiliation

Department of Pharmaceutics Faculty of pharmacy. Mansoura University, Mansour. 35516. Egypt.

Email

abd-el-gawad.abd-el-gawad@yahoo.com

City

-

Orcid

-

First Name

Osama

Last Name

Soliman

MiddleName

-

Affiliation

Department of Pharmaceutics Faculty of pharmacy. Mansoura University, Mansour. 35516. Egypt.

Email

osama.soliman@yahoo.com

City

-

Orcid

-

First Name

Mohamed

Last Name

Shams

MiddleName

-

Affiliation

Department of Pharmaceutics Faculty of pharmacy. Mansoura University, Mansour. 35516. Egypt.

Email

mohamed.shams@yahoo.com

City

-

Orcid

-

First Name

Doaa

Last Name

Maria

MiddleName

-

Affiliation

Department of Pharmaceutics Faculty of pharmacy. Mansoura University, Mansour. 35516. Egypt.

Email

doaa.maria@yahoo.com

City

-

Orcid

-

Volume

18

Article Issue

1

Related Issue

23548

Issue Date

2009-06-01

Receive Date

2009-02-04

Publish Date

2009-06-01

Page Start

12

Page End

22

Print ISSN

1110-5089

Online ISSN

2356-9786

Link

https://zjps.journals.ekb.eg/article_169353.html

Detail API

https://zjps.journals.ekb.eg/service?article_code=169353

Order

2

Type

Original Article

Type Code

862

Publication Type

Journal

Publication Title

Zagazig Journal of Pharmaceutical Sciences

Publication Link

https://zjps.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023